至少200名乳癌病患,在邱德拔医院的生长因子受体2(简称HER2)检测出错。卫生部高级政务部长许宝琨今日(4日)在国会遭到议员们质询,表示院方联系受影响病患,以评估他们是否因过度或不必要治疗,出现任何副作用。

去年12月,邱德拔医院承认有乳癌病患,他们的HER2检测结果,可能被错归为阳性,调查也发现部份检测有误,于11月22日向国立保健集团上报此事;24日通报卫生部。院内化验室暂停所有HER2检测。

HER2的治疗会使用名为赫赛汀(Herceptin,或称Trastuzumab)的药物,常见副作用包括腹泻、发冷和发烧;至少3到4巴仙使用者,则可能出现心脏问题。

从2012年开始,邱德拔医院就进行上述检测。许宝琨解释,为谨慎起见院方也追溯到2012年起,接受有关检测的病患,他们的组织样本都已被送往多个外部实验室,以加快重新检测的过程。

许宝琨坦言,理解病患们的焦虑和不安,卫生部与院方已确保受影响病患获得协助。院方也成立联合护理团队,检讨受影响病患的医药费,为病患所接受的不必要治疗作出全额退款。

 

 

 

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments
You May Also Like

How much of my salary should I invest?

By SingSaver  Many Singaporeans want to know how much of their salary should…

Time to make a decision on S’pore: SDP

Jewel Philemon/ Pictures by Jeremy Philemon The Singapore Democratic Party (SDP) unveiled…

Animal clinic collects wheel-clamp release fee of $300 despite not being authorised

Parked your car in a private space and had your car wheel-clamped?…

Contaminated lettuces with “possible human carcinogen”, slip past AVA, and land in supermarkets in Singapore

The Agri-Food and Veterinary Authority (AVA) has let a batch of contaminated…